N/A
Loading page data
Please wait a moment
Loading page data
Please wait a moment
Second Floor, 150 Fleet Street,
London, EC4A 2DQ.
+44 203-837-5656
108 W 39th Street, Ste 1006,
PMB2219, New York, NY 10018
+1 646-878-6329
IT Unit No. 504, 5th Floor, Icon
Tower, Baner, Pune - 411045.
+91 906 779 3500
The development of genetic engineering has opened many possibilities of expression for research purposes. Significant advancements in technology have enabled expression of mammalian protein cells in large scale. The mammalian cells are generally used for the production of therapeutic proteins and antibodies.
Mammalian cell expression kits are traditionally seen to be expensive due to the cost associated with specialized media, transfection reagents, consumables, and the professional workforce required. Nowadays mammalian cell expression kits have become the dominant recombinant protein production system for the clinical application. The main challenges observed with using mammalian cell expression kits is the reduced efficiency and levels of the protein expressed.
Increasing research activities and large-scale production of vaccines and antibodies that require kits and reagents are primarily responsible for raising the demand and driving the growth of the global mammalian cell expression kits market.
The growing prevalence of chronic disease globally is further growing the demand of biologics and later contributing in driving the growth of mammalian cell expression kits market. However, the lack of efficient systems for the detection of post-translational modifications is expected to limit the growth of the global mammalian cell expression kits market.
Lack of cost-effective and efficient systems remains a significant hurdle for the growth of the global mammalian cell expression kits market.
